tirzepatide and osa Breakthrough Treatment for Obstructive Sleep Apnea: FDA Approves Zepbound ( Tirzepatide) Tirzepatide Makes a Big Splash,

Clinical trials showed average weight loss of 20-25% of body weight with tirzepatide at the highest doses, compared to 15-17% with semaglutide

Complete loss of expression of H3K27me3 was observed in 72% of malignant peripheral nerve sheath tumors compared with 37% of loss found in melanomas, including primary desmoplastic/fusiform cell melanomas, indicating that complete loss of H3K27me3 is not specific for malignant peripheral nerve sheath tumor in the differential diagnosis, especially with desmoplastic/fusiform cell melanomas

This is smaller (in 2020 real terms) than at any point since 1961 (Extended Data Fig

Lead times range from 5 to 14 business days for standard orders

Consumer psychology during resolution season creates both opportunity and vulnerability

Its very frustrating I acknowledge that because this is a treatment that many millions of Australians are anticipating and thats also causing a lot of turmoil in the market